Table 1.
Clinical characteristics of subjects enrolled in this study.
| Variables | Training phase | Validation phase | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Plasma samples | Tissues samples | Plasma samples | ||||||||
| CRC | adenoma | HC | CRC | adenoma | HC | Pre/post | CRC | adenoma | HC | |
| Number | 15 | 15 | 15 | 20 | 20 | 20 | 15 | 80 | 50 | 30 |
| Age (mean±SD) | 62.4 ± 10.9 | 61.2 ± 12.1 | 61.4 ± 11.2 | 61.5 ± 10.6 | 60.2 ± 11.7 | 58.4 ± 10.8 | 62.6 ± 9.3 | 63.7 ± 9.2 | 62.2 ± 9.6 | 59.4 ± 10.3 |
| Gender | ||||||||||
| Male | 10 | 12 | 10 | 14 | 15 | 13 | 11 | 53 | 34 | 19 |
| Female | 5 | 3 | 5 | 6 | 5 | 7 | 4 | 27 | 16 | 11 |
| Drinking status | ||||||||||
| never | 4 | 2 | 3 | 6 | 4 | 6 | 3 | 29 | 19 | 12 |
| ever | 11 | 13 | 12 | 14 | 16 | 14 | 12 | 51 | 31 | 18 |
| Tumor stage | ||||||||||
| I | 5 | 5 | 4 | 24 | ||||||
| II | 6 | 8 | 6 | 31 | ||||||
| III | 2 | 4 | 3 | 16 | ||||||
| IV | 2 | 3 | 2 | 9 | ||||||